Bexilin

Inhaler: Each actuation delivers Salbutamol BP 100 µg suspended in propellant HFA-134a up to the required volume.

Bexilin contains salbutamol, a selective beta2-agonist that is chemically related to isoprenaline. It is not metabolised by COMT and monoamine oxidase, therefore the action of the drug lasts longer than isoprenaline. It acts by stimulating the beta2-receptor cells of the smooth muscles in the bronchioles and uterus.

It has minimal cardiac stimulant effect and does not cause hypertension.

It is used for the relief of bronchospasm in patients with reversible obstructive airway disease and relaxation of uterine smooth muscles to delay threatened abortion.

It is contraindicated in patients that are hypersensitive to the drug or cases of thyrotoxicosis.

Use cautiously in:

• Cardiac disease, hypertension, diabetes mellitus, glaucoma, seizure disorder, hyperthyroidism, exercise-induced bronchospasm, prostatic hypertrophy
• Elderly patients
• Pregnant or breastfeeding patients
• Children.

The inhaler is a pressurised canister and should be kept away from sunlight and heat. Do not puncture, break or burn even when apparently empty.